Fig. 4: In depth analyses of patient 16's tumor compared to other PitNET samples or healthy references. | BJC Reports

Fig. 4: In depth analyses of patient 16's tumor compared to other PitNET samples or healthy references.

From: Whole genome sequencing and single-cell transcriptomics identify KMT2D inactivation as a potential new driver for pituitary tumors: a case report

Fig. 4

a Differential gene expression analysis results showing HALLMARKS up- and downregulated between patient 16 and reference. b Tumor and immune cells proportion in PitNET samples where scRNA-seq is available. c Immune cells composition in the PitNETs predicted by Azimuth.

Back to article page